Experimental drug shows promise for tough uterine cancers
NCT ID NCT03668340
First seen Jan 12, 2026 · Last updated May 14, 2026 · Updated 19 times
Summary
This study tests an experimental drug called AZD1775 in 49 women whose uterine cancer has come back or spread. The goal is to see if the drug can shrink tumors or slow cancer growth. Participants must have a specific type of uterine cancer (serous carcinoma or carcinosarcoma) and have tried other treatments before.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for UTERINE CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Dana Farber Cancer Institute
Boston, Massachusetts, 02215, United States
Conditions
Explore the condition pages connected to this study.